N-acetylcysteine derivative inhibits CD40-dependent proinflammatory properties of human pancreatic duct cells

Pancreas

Volumn 36, Issue 4, 2008, Pages 363-368

  Vosters, Olivier ^a,b,d   Beuneu, Claire ^a,b   Goldman, Michel ^a,b   Verhasselt, Valérie ^c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b JDRF Center for Beta Cell Therapy in Diabetes   (Belgium)

^c INSERM   (France)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

CAPAN 2; CD40; Islet transplantation; NF B; Pancreatic duct cells; Type 1 diabetes mellitus

Indexed keywords

ACETYLCYSTEINE DERIVATIVE; CD40 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; NACYSTELYN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ACETYLCYSTEINE; ADENOCARCINOMA; ANTIGENS, CD40; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; LYSINE; NF-KAPPA B; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 42549144939     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31815c75d4     Document Type: Article

References (50)

1. Bouwens L, Pipeleers DG. Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia. 1998;41:629-633.
2. Pavlovic D, van de Winkel M, van der Auwera B, et al. Effect of interferon-gamma and glucose on major histocompatibility complex class I and class II expression by pancreatic beta- and non-beta-cells. J Clin Endocrinol Metab. 1997;82:2329-2336.
3. Pavlovic D, Chen MC, Bouwens L, et al. Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes. 1999;48:29-33.
4. Pipeleers D, Hoorens A, Marichal-Pipeleers M, et al. Role of pancreatic beta-cells in the process of beta-cell death. Diabetes. 2001;50:(suppl 1):S52-S57.
5. Ling Z, Pipeleers DG. Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest. 1996;98:2805-2812.
6. Keymeulen B, Ling Z, Gorus FK, et al. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia. 1998;41:452-459.
7. Movahedi B, Van de Casteele M, Caluwé N, et al. Human pancreatic duct cells can produce tumor necrosis factor-α that damages neighbouring beta cells and activates dendritic cells. Diabetologia. 2004;47:998-1008.
8. Vosters O, Beuneu C, Nagy N, et al. CD40 expression on human pancreatic duct cells: role in nuclear factor-kappa B activation and production of pro-inflammatory cytokines. Diabetologia. 2004;47:660-668.
9. Woltman AM, de Haij S, Boonstra JG, et al. Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol. 2000;11:2044-2055.
10. Propst SM, Denson R, Rothstein E, et al. Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: implications for the role of epithelial CD40 in airway inflammation. J Immunol. 2000;165:2214-2221.
11. Afford SC, Ahmed-Choudhury J, Randhawa S et al. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB J. 2001;15:2345-2354.
12. Propst SM, Estell K, Schwiebert LM. CD40-mediated activation of NF-kappa B in airway epithelial cells. J Biol Chem. 2002;277:37054-37063.
13. de Haij S, Woltman AM, Bakker AC, et al. Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoids. Br J Pharmacol. 2002;137:197-204.
14. Amsellem C, Dirieu I, Chambe MT, et al. In vitro expression of fas and CD40 and induction of apoptosis in human cystic fibrosis airway epithelial cells. Respir Med. 2002;96:244-249.
15. Berberich I, Shu GL, Clark EA. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J Immunol. 1994;153:4357-4366.
16. van Kooten C, Banchereau J. Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol. 1997;9:330-337.
17. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol. 2000;67:2-17.
18. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391:591-594.
19. Freedman JE. CD40 ligand-assessing risk instead of damage? N Engl J Med. 2003;348:1163-1165.
20. Heeschen C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med. 2003;348:1104-1111.
21. Caux C, Massacrier C, Vanbervliet B, et al. Activation of human dendritic cells through CD40 cross-linking. J Exp Med. 1994;180:1263-1272.
22. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol. 1998;16:111-135.
23. O'Sullivan BJ, Thomas R. CD40 ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-kappaB. J Immunol. 2002;168:5491-5498.
24. Homann D, Jahreis A, Wolfe T, et al. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity. 2002;16:403-415.
25. Moore WV, Chu W, Tong PY, et al. Prevention of autoimmune diabetes in the DRBB rat by CD40/154 blockade. J Autoimmun. 2002;19:139-145.
26. Frossard JL, Kwak B, Chanson M, et al. CD40 ligand-deficient mice are protected against cerulein-induced acute pancreatitis and pancreatitis- associated lung injury. Gastroenterology. 2001;121:184-194.
27. Nagy AM, Vanderbist F, Parij N, et al. Effect of the mucoactive drug nacystelyn on the respiratory burst of human blood polymorphonuclear neutrophils. Pulm Pharmacol Ther. 1997;10:287-292.
28. Vosters O, Nève J. Inhibitory effects of thiol-containing drugs on erythrocyte oxidative damages investigated with an improved assay system. Talanta. 2002;595-600.
29. Antonicelli F, Parmentier M, Drost EM, et al. Nacystelyn inhibits oxidant-mediated interleukine-8 expression and NF-kappaB nuclear binding in alveolar epithelial cells. Free Radic Biol Med. 2002;32:492-502.
30. Vosters O, Nève J, De Wit D, et al. Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory T cells. Transplantation. 2003;75:383-389.
31. Verhasselt V, Vanden Berghe W, Vanderheyde N, et al. N-acetyl- L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-κB inhibition. J Immunol. 1999;162:2569-2574.
32. Beuneu C, Vosters O, Ling Z, et al. N-acetylcysteine derivative inhibits procoagulant activity of human islet cells. Diabetologia. 2007;50:343-347.
33. De Breuck S, Lardon J, Rooman I, et al. Netrin-1 expression in fetal and regenerating rat pancreas and its effect on the migration of human pancreatic duct and porcine islet precursor cells. Diabetologia. 2003;46:926-933.
34. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A. 1989;86:2336-2340.
35. Stordeur P, Zhou L, Goldman M. Analysis of spontaneous mRNA cytokine production in peripheral blood. J Immunol Methods. 2002;261:195-197.
36. Stordeur P, Zhou L, Byl B, et al. Immune monitoring in whole blood using real-time PCR. J Immunol Methods. 2003;276:69-77.
37. Brisseau G, Dackwin A, Cheung P, et al. Posttranscriptional regulation of macrophage tissue factor expression by antioxidants. Blood. 1995;85:1025-1035.
38. Ling Z, Van de Casteele M, Eizirik DL, et al. Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes. 2000;49:340-345.
39. Thomas HE, Darwiche R, Corbett JA, et al. Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production. Diabetes. 2002;51:311-316.
40. Tabatabaie T, Vasquez-Weldon A, Moore DR, et al. Free radicals and the pathogenesis of type 1 diabetes: beta-cell cytokine-mediated free radical generation via cyclooxygenase-2. Diabetes. 2003;52:1994-1999.
41. Gross V, Leser HG, Heinisch A, et al. Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology. 1993;40:522-530.
42. Kim H, Seo JY, Roh KH, et al. Suppression of NF-JB activation and cytokine production by N-acetylcysteine in pancreatic acinar cells. Free Radic Biol Med. 2000;29:674-683.
43. Ramudo L, Manso MA, Vicente S, et al. Pro- and anti-inflammatory response of acinar cells during acute pancreatitis. Effect of N-acetyl cysteine. Cytokine. 2005;32:125-131.
44. + T cells play an important role in acute experimental pancreatitis in mice. Gastroenterology. 2000;118:582-590.
45. Shapiro AM, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230-238.
46. Xu H, Zhang X, Mannon RB, et al. Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J Clin Invest. 2006;116:769-774.
47. Kover KL, Geng Z, Hess DM, et al. Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat. Diabetes. 2000;49:1666-1670.
48. Phillips NE, Markees TG, Mordes JP, et al. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance. J Immunol. 2003;170:3015-3023.
49. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med. 2006;12:304-306.
50. Yamada A, Sayegh MH. The CD154-CD40 costimulatory pathway in transplantation. Transplantation. 2002;73:S36-S39.